Genetic diseases company 4s3 Bioscience lands funding from a healthcare subsidiary of the family office of the wealthy Pritzker and Vlock families.
Genetic disease company 4s3 Bioscience has raised $20m from a subsidiary of KLP Enterprises, a trust formed by the investment office of the wealthy Pritzker and Vlock families.
KLP subsidiary Alopexx Entreprises, a healthcare company founded in 2011, will partner with US-based 4s3 to grow the company as well as providing the Series A financing on Monday.
Daniel Vlock, chief executive of Alopexx, said: "We are excited to be working with 4s3. We are very impressed with the…
